Effective palliation of advanced breast cancer with weekly low dose epirubicin
- 1 February 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (2), 357-360
- https://doi.org/10.1016/0277-5379(89)90030-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Clinical trials in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- A phase II study of oral weekly 4-demethoxydaunorubicin in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- The clinical course of bone metastases from breast cancerBritish Journal of Cancer, 1987
- New anthracycline analogs in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.Journal of Clinical Oncology, 1986
- A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.Journal of Clinical Oncology, 1985
- Weekly low dose doxorubicin monotherapy in metastatic breast cancer resistant to previous hormonal and cytostatic treatmentBreast Cancer Research and Treatment, 1985
- Mini-dose weekly adriamycin therapy for patients with advanced malignant disease at increased risk for adriamycin toxicityAmerican Journal of Clinical Oncology, 1983
- An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patientsCancer, 1980
- ADRIAMYCIN GIVEN AS A WEEKLY SCHEDULE WITHOUT A LOADING COURSE - CLINICALLY EFFECTIVE WITH REDUCED INCIDENCE OF CARDIOTOXICITY1980